nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—L-DOPA—Melphalan—peripheral nervous system neoplasm	0.595	1	CrCrCtD
Carbidopa—DDC—Catecholamine biosynthesis—TH—peripheral nervous system neoplasm	0.023	0.234	CbGpPWpGaD
Carbidopa—DDC—Parkinsons Disease Pathway—PINK1—peripheral nervous system neoplasm	0.019	0.193	CbGpPWpGaD
Carbidopa—Metyrosine—TH—peripheral nervous system neoplasm	0.00896	1	CrCbGaD
Carbidopa—DDC—Dopamine metabolism—TH—peripheral nervous system neoplasm	0.00896	0.0912	CbGpPWpGaD
Carbidopa—DDC—Biogenic Amine Synthesis—TH—peripheral nervous system neoplasm	0.00799	0.0813	CbGpPWpGaD
Carbidopa—DDC—Amine-derived hormones—TH—peripheral nervous system neoplasm	0.00759	0.0772	CbGpPWpGaD
Carbidopa—DDC—Nicotine Activity on Dopaminergic Neurons—TH—peripheral nervous system neoplasm	0.0061	0.0621	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00465	0.0474	CbGpPWpGaD
Carbidopa—DDC—Dopaminergic Neurogenesis—TH—peripheral nervous system neoplasm	0.00459	0.0467	CbGpPWpGaD
Carbidopa—DDC—Parkinsons Disease Pathway—TH—peripheral nervous system neoplasm	0.0038	0.0387	CbGpPWpGaD
Carbidopa—DDC—nerve—peripheral nervous system neoplasm	0.00185	0.414	CbGeAlD
Carbidopa—DDC—ganglion—peripheral nervous system neoplasm	0.00183	0.409	CbGeAlD
Carbidopa—DDC—Parkinsons Disease Pathway—CASP3—peripheral nervous system neoplasm	0.00155	0.0157	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.00134	0.0136	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.00123	0.0125	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—TH—peripheral nervous system neoplasm	0.00106	0.0108	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.001	0.0102	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000999	0.0102	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000891	0.00907	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000825	0.0084	CbGpPWpGaD
Carbidopa—DDC—brainstem—peripheral nervous system neoplasm	0.000794	0.178	CbGeAlD
Carbidopa—DDC—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000558	0.00568	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000499	0.00508	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GNS—peripheral nervous system neoplasm	0.000403	0.0041	CbGpPWpGaD
Carbidopa—DDC—Metabolism—NME1—peripheral nervous system neoplasm	0.000387	0.00393	CbGpPWpGaD
Carbidopa—DDC—Metabolism—COX2—peripheral nervous system neoplasm	0.000372	0.00379	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000261	0.00266	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ENO2—peripheral nervous system neoplasm	0.000244	0.00249	CbGpPWpGaD
Carbidopa—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000209	0.000713	CcSEcCtD
Carbidopa—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000209	0.000713	CcSEcCtD
Carbidopa—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000712	CcSEcCtD
Carbidopa—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000208	0.000711	CcSEcCtD
Carbidopa—Headache—Tretinoin—peripheral nervous system neoplasm	0.000208	0.000711	CcSEcCtD
Carbidopa—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000208	0.000711	CcSEcCtD
Carbidopa—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000208	0.000709	CcSEcCtD
Carbidopa—Constipation—Vincristine—peripheral nervous system neoplasm	0.000208	0.000709	CcSEcCtD
Carbidopa—Pain—Vincristine—peripheral nervous system neoplasm	0.000208	0.000709	CcSEcCtD
Carbidopa—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000709	CcSEcCtD
Carbidopa—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000709	CcSEcCtD
Carbidopa—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000709	CcSEcCtD
Carbidopa—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000208	0.000709	CcSEcCtD
Carbidopa—Rash—Melphalan—peripheral nervous system neoplasm	0.000207	0.000707	CcSEcCtD
Carbidopa—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000207	0.000706	CcSEcCtD
Carbidopa—DDC—Metabolism—BCHE—peripheral nervous system neoplasm	0.000206	0.0021	CbGpPWpGaD
Carbidopa—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000206	0.000704	CcSEcCtD
Carbidopa—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000205	0.000701	CcSEcCtD
Carbidopa—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000205	0.0007	CcSEcCtD
Carbidopa—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000205	0.000699	CcSEcCtD
Carbidopa—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000203	0.000692	CcSEcCtD
Carbidopa—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000201	0.000685	CcSEcCtD
Carbidopa—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000685	CcSEcCtD
Carbidopa—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.0002	0.000684	CcSEcCtD
Carbidopa—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.0002	0.000684	CcSEcCtD
Carbidopa—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000199	0.00068	CcSEcCtD
Carbidopa—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000199	0.00068	CcSEcCtD
Carbidopa—Nausea—Topotecan—peripheral nervous system neoplasm	0.000199	0.00068	CcSEcCtD
Carbidopa—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000199	0.000678	CcSEcCtD
Carbidopa—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000678	CcSEcCtD
Carbidopa—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000198	0.000677	CcSEcCtD
Carbidopa—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000198	0.000674	CcSEcCtD
Carbidopa—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000198	0.000674	CcSEcCtD
Carbidopa—DDC—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000197	0.002	CbGpPWpGaD
Carbidopa—Infection—Etoposide—peripheral nervous system neoplasm	0.000195	0.000667	CcSEcCtD
Carbidopa—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000666	CcSEcCtD
Carbidopa—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000195	0.000666	CcSEcCtD
Carbidopa—Nausea—Melphalan—peripheral nervous system neoplasm	0.000195	0.000666	CcSEcCtD
Carbidopa—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000664	CcSEcCtD
Carbidopa—DDC—Metabolism—TH—peripheral nervous system neoplasm	0.000194	0.00198	CbGpPWpGaD
Carbidopa—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000662	CcSEcCtD
Carbidopa—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000193	0.000658	CcSEcCtD
Carbidopa—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000193	0.000658	CcSEcCtD
Carbidopa—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000192	0.000655	CcSEcCtD
Carbidopa—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000192	0.000655	CcSEcCtD
Carbidopa—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000191	0.000654	CcSEcCtD
Carbidopa—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00019	0.000649	CcSEcCtD
Carbidopa—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000647	CcSEcCtD
Carbidopa—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000188	0.00064	CcSEcCtD
Carbidopa—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000187	0.000637	CcSEcCtD
Carbidopa—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000186	0.000635	CcSEcCtD
Carbidopa—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.000634	CcSEcCtD
Carbidopa—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000634	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000185	0.000633	CcSEcCtD
Carbidopa—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000184	0.000628	CcSEcCtD
Carbidopa—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000627	CcSEcCtD
Carbidopa—Pain—Cisplatin—peripheral nervous system neoplasm	0.000184	0.000627	CcSEcCtD
Carbidopa—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000181	0.000617	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000615	CcSEcCtD
Carbidopa—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000613	CcSEcCtD
Carbidopa—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000612	CcSEcCtD
Carbidopa—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000179	0.000611	CcSEcCtD
Carbidopa—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000178	0.000609	CcSEcCtD
Carbidopa—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000177	0.000604	CcSEcCtD
Carbidopa—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000177	0.000603	CcSEcCtD
Carbidopa—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000603	CcSEcCtD
Carbidopa—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000599	CcSEcCtD
Carbidopa—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000175	0.000599	CcSEcCtD
Carbidopa—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000175	0.000597	CcSEcCtD
Carbidopa—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000174	0.000595	CcSEcCtD
Carbidopa—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000173	0.00059	CcSEcCtD
Carbidopa—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000172	0.000589	CcSEcCtD
Carbidopa—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000171	0.000585	CcSEcCtD
Carbidopa—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000171	0.000584	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00017	0.00058	CcSEcCtD
Carbidopa—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00017	0.00058	CcSEcCtD
Carbidopa—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00017	0.000579	CcSEcCtD
Carbidopa—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000579	CcSEcCtD
Carbidopa—Pain—Etoposide—peripheral nervous system neoplasm	0.000168	0.000574	CcSEcCtD
Carbidopa—Constipation—Etoposide—peripheral nervous system neoplasm	0.000168	0.000574	CcSEcCtD
Carbidopa—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000574	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000569	CcSEcCtD
Carbidopa—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000167	0.000569	CcSEcCtD
Carbidopa—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000166	0.000567	CcSEcCtD
Carbidopa—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000566	CcSEcCtD
Carbidopa—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000557	CcSEcCtD
Carbidopa—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000554	CcSEcCtD
Carbidopa—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000162	0.000553	CcSEcCtD
Carbidopa—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000161	0.000551	CcSEcCtD
Carbidopa—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000551	CcSEcCtD
Carbidopa—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000161	0.000549	CcSEcCtD
Carbidopa—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000161	0.000548	CcSEcCtD
Carbidopa—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00016	0.000547	CcSEcCtD
Carbidopa—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000159	0.000543	CcSEcCtD
Carbidopa—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000159	0.000542	CcSEcCtD
Carbidopa—DDC—Metabolism—GNAS—peripheral nervous system neoplasm	0.000158	0.00161	CbGpPWpGaD
Carbidopa—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000158	0.00054	CcSEcCtD
Carbidopa—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000158	0.000539	CcSEcCtD
Carbidopa—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000535	CcSEcCtD
Carbidopa—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000156	0.000534	CcSEcCtD
Carbidopa—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000533	CcSEcCtD
Carbidopa—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000531	CcSEcCtD
Carbidopa—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000156	0.000531	CcSEcCtD
Carbidopa—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000156	0.000531	CcSEcCtD
Carbidopa—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000531	CcSEcCtD
Carbidopa—DDC—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000155	0.00158	CbGpPWpGaD
Carbidopa—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000155	0.00053	CcSEcCtD
Carbidopa—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000527	CcSEcCtD
Carbidopa—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000154	0.000527	CcSEcCtD
Carbidopa—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000154	0.000526	CcSEcCtD
Carbidopa—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000523	CcSEcCtD
Carbidopa—Rash—Vincristine—peripheral nervous system neoplasm	0.000153	0.000523	CcSEcCtD
Carbidopa—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000153	0.000522	CcSEcCtD
Carbidopa—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000519	CcSEcCtD
Carbidopa—Headache—Vincristine—peripheral nervous system neoplasm	0.000152	0.000519	CcSEcCtD
Carbidopa—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00015	0.000511	CcSEcCtD
Carbidopa—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.00051	CcSEcCtD
Carbidopa—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000147	0.000502	CcSEcCtD
Carbidopa—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000145	0.000495	CcSEcCtD
Carbidopa—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000493	CcSEcCtD
Carbidopa—Nausea—Vincristine—peripheral nervous system neoplasm	0.000144	0.000492	CcSEcCtD
Carbidopa—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000492	CcSEcCtD
Carbidopa—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000492	CcSEcCtD
Carbidopa—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.00049	CcSEcCtD
Carbidopa—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000488	CcSEcCtD
Carbidopa—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000484	CcSEcCtD
Carbidopa—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000141	0.000482	CcSEcCtD
Carbidopa—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000481	CcSEcCtD
Carbidopa—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000139	0.000475	CcSEcCtD
Carbidopa—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000468	CcSEcCtD
Carbidopa—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000137	0.000466	CcSEcCtD
Carbidopa—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000464	CcSEcCtD
Carbidopa—Rash—Cisplatin—peripheral nervous system neoplasm	0.000135	0.000462	CcSEcCtD
Carbidopa—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000135	0.000462	CcSEcCtD
Carbidopa—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000135	0.00046	CcSEcCtD
Carbidopa—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000455	CcSEcCtD
Carbidopa—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000455	CcSEcCtD
Carbidopa—Tension—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000453	CcSEcCtD
Carbidopa—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000452	CcSEcCtD
Carbidopa—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000448	CcSEcCtD
Carbidopa—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000446	CcSEcCtD
Carbidopa—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00013	0.000444	CcSEcCtD
Carbidopa—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000444	CcSEcCtD
Carbidopa—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000128	0.000435	CcSEcCtD
Carbidopa—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000435	CcSEcCtD
Carbidopa—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000433	CcSEcCtD
Carbidopa—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.00043	CcSEcCtD
Carbidopa—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000428	CcSEcCtD
Carbidopa—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000125	0.000427	CcSEcCtD
Carbidopa—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000426	CcSEcCtD
Carbidopa—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000424	CcSEcCtD
Carbidopa—Rash—Etoposide—peripheral nervous system neoplasm	0.000124	0.000423	CcSEcCtD
Carbidopa—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000124	0.000423	CcSEcCtD
Carbidopa—Headache—Etoposide—peripheral nervous system neoplasm	0.000123	0.000421	CcSEcCtD
Carbidopa—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000421	CcSEcCtD
Carbidopa—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000419	CcSEcCtD
Carbidopa—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000418	CcSEcCtD
Carbidopa—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000416	CcSEcCtD
Carbidopa—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000415	CcSEcCtD
Carbidopa—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000414	CcSEcCtD
Carbidopa—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000413	CcSEcCtD
Carbidopa—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000413	CcSEcCtD
Carbidopa—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.00041	CcSEcCtD
Carbidopa—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000408	CcSEcCtD
Carbidopa—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000405	CcSEcCtD
Carbidopa—Cough—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000403	CcSEcCtD
Carbidopa—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000402	CcSEcCtD
Carbidopa—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000117	0.0004	CcSEcCtD
Carbidopa—Nausea—Etoposide—peripheral nervous system neoplasm	0.000117	0.000399	CcSEcCtD
Carbidopa—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000398	CcSEcCtD
Carbidopa—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000396	CcSEcCtD
Carbidopa—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000395	CcSEcCtD
Carbidopa—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000393	CcSEcCtD
Carbidopa—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000392	CcSEcCtD
Carbidopa—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000391	CcSEcCtD
Carbidopa—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000388	CcSEcCtD
Carbidopa—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000385	CcSEcCtD
Carbidopa—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000384	CcSEcCtD
Carbidopa—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000383	CcSEcCtD
Carbidopa—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000382	CcSEcCtD
Carbidopa—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000111	0.00038	CcSEcCtD
Carbidopa—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000377	CcSEcCtD
Carbidopa—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000376	CcSEcCtD
Carbidopa—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000375	CcSEcCtD
Carbidopa—Infection—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000374	CcSEcCtD
Carbidopa—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000372	CcSEcCtD
Carbidopa—Shock—Epirubicin—peripheral nervous system neoplasm	0.000108	0.00037	CcSEcCtD
Carbidopa—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.00037	CcSEcCtD
Carbidopa—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000369	CcSEcCtD
Carbidopa—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000369	CcSEcCtD
Carbidopa—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000364	CcSEcCtD
Carbidopa—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000363	CcSEcCtD
Carbidopa—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000362	CcSEcCtD
Carbidopa—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000359	CcSEcCtD
Carbidopa—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000359	CcSEcCtD
Carbidopa—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000355	CcSEcCtD
Carbidopa—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000352	CcSEcCtD
Carbidopa—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000351	CcSEcCtD
Carbidopa—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000348	CcSEcCtD
Carbidopa—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000346	CcSEcCtD
Carbidopa—Shock—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000343	CcSEcCtD
Carbidopa—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	9.99e-05	0.000341	CcSEcCtD
Carbidopa—Insomnia—Epirubicin—peripheral nervous system neoplasm	9.97e-05	0.000341	CcSEcCtD
Carbidopa—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	9.9e-05	0.000338	CcSEcCtD
Carbidopa—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	9.86e-05	0.000337	CcSEcCtD
Carbidopa—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	9.83e-05	0.000336	CcSEcCtD
Carbidopa—Somnolence—Epirubicin—peripheral nervous system neoplasm	9.8e-05	0.000335	CcSEcCtD
Carbidopa—Anorexia—Doxorubicin—peripheral nervous system neoplasm	9.73e-05	0.000332	CcSEcCtD
Carbidopa—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	9.71e-05	0.000331	CcSEcCtD
Carbidopa—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	9.59e-05	0.000327	CcSEcCtD
Carbidopa—Hypotension—Doxorubicin—peripheral nervous system neoplasm	9.53e-05	0.000326	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	9.52e-05	0.000325	CcSEcCtD
Carbidopa—Fatigue—Epirubicin—peripheral nervous system neoplasm	9.51e-05	0.000325	CcSEcCtD
Carbidopa—Pain—Epirubicin—peripheral nervous system neoplasm	9.43e-05	0.000322	CcSEcCtD
Carbidopa—Constipation—Epirubicin—peripheral nervous system neoplasm	9.43e-05	0.000322	CcSEcCtD
Carbidopa—Insomnia—Doxorubicin—peripheral nervous system neoplasm	9.23e-05	0.000315	CcSEcCtD
Carbidopa—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	9.16e-05	0.000313	CcSEcCtD
Carbidopa—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	9.1e-05	0.000311	CcSEcCtD
Carbidopa—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	9.09e-05	0.00031	CcSEcCtD
Carbidopa—Somnolence—Doxorubicin—peripheral nervous system neoplasm	9.07e-05	0.00031	CcSEcCtD
Carbidopa—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	9.02e-05	0.000308	CcSEcCtD
Carbidopa—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	8.98e-05	0.000307	CcSEcCtD
Carbidopa—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	8.87e-05	0.000303	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.81e-05	0.000301	CcSEcCtD
Carbidopa—Fatigue—Doxorubicin—peripheral nervous system neoplasm	8.8e-05	0.0003	CcSEcCtD
Carbidopa—Urticaria—Epirubicin—peripheral nervous system neoplasm	8.76e-05	0.000299	CcSEcCtD
Carbidopa—Pain—Doxorubicin—peripheral nervous system neoplasm	8.72e-05	0.000298	CcSEcCtD
Carbidopa—Constipation—Doxorubicin—peripheral nervous system neoplasm	8.72e-05	0.000298	CcSEcCtD
Carbidopa—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	8.72e-05	0.000298	CcSEcCtD
Carbidopa—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	8.72e-05	0.000298	CcSEcCtD
Carbidopa—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	8.41e-05	0.000287	CcSEcCtD
Carbidopa—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	8.34e-05	0.000285	CcSEcCtD
Carbidopa—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	8.12e-05	0.000277	CcSEcCtD
Carbidopa—Urticaria—Doxorubicin—peripheral nervous system neoplasm	8.11e-05	0.000277	CcSEcCtD
Carbidopa—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	8.07e-05	0.000275	CcSEcCtD
Carbidopa—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	8.07e-05	0.000275	CcSEcCtD
Carbidopa—Asthenia—Epirubicin—peripheral nervous system neoplasm	7.91e-05	0.00027	CcSEcCtD
Carbidopa—Pruritus—Epirubicin—peripheral nervous system neoplasm	7.8e-05	0.000266	CcSEcCtD
Carbidopa—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	7.54e-05	0.000258	CcSEcCtD
Carbidopa—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	7.52e-05	0.000257	CcSEcCtD
Carbidopa—Asthenia—Doxorubicin—peripheral nervous system neoplasm	7.32e-05	0.00025	CcSEcCtD
Carbidopa—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.29e-05	0.000249	CcSEcCtD
Carbidopa—Pruritus—Doxorubicin—peripheral nervous system neoplasm	7.22e-05	0.000246	CcSEcCtD
Carbidopa—Vomiting—Epirubicin—peripheral nervous system neoplasm	7.01e-05	0.000239	CcSEcCtD
Carbidopa—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.98e-05	0.000238	CcSEcCtD
Carbidopa—Rash—Epirubicin—peripheral nervous system neoplasm	6.95e-05	0.000237	CcSEcCtD
Carbidopa—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.95e-05	0.000237	CcSEcCtD
Carbidopa—Headache—Epirubicin—peripheral nervous system neoplasm	6.91e-05	0.000236	CcSEcCtD
Carbidopa—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.75e-05	0.00023	CcSEcCtD
Carbidopa—Nausea—Epirubicin—peripheral nervous system neoplasm	6.55e-05	0.000224	CcSEcCtD
Carbidopa—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.49e-05	0.000221	CcSEcCtD
Carbidopa—Rash—Doxorubicin—peripheral nervous system neoplasm	6.43e-05	0.00022	CcSEcCtD
Carbidopa—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.43e-05	0.000219	CcSEcCtD
Carbidopa—Headache—Doxorubicin—peripheral nervous system neoplasm	6.39e-05	0.000218	CcSEcCtD
Carbidopa—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.06e-05	0.000207	CcSEcCtD
Carbidopa—DDC—Metabolism—AKT1—peripheral nervous system neoplasm	4.28e-05	0.000435	CbGpPWpGaD
